-
1
Modular platform for RNA delivery developed.
-
2
Utilizes supramolecular chemistry.
-
3
Offers alternative to lipid nanoparticles.
-
4
Carriers self-assemble through host-guest interactions.
-
5
Particles are typically under 150 nm.
-
6
Effective across various RNA classes.
-
7
Potential for improved RNA therapies in cancer.
-
8
Adaptable for scalable production during outbreaks.
Original Source(s)
Related Content
Precision Therapies: The Last Mile
Why therapies still take years to reach the patients who need them
by Pete Harbin
March 12, 2026
-
8 min
Innovation Awards 2025: Vote for Your Winner
Help us choose the most impactful drug development and manufacturing technology of 2025
March 11, 2026
-
1 min
Engineering CAR T Cells to Resist Tumor Immune Suppression
CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models
March 9, 2026
-
2 min
